- Published 11 Jun 2025
Innovations in Peptide Science 2025
CatSci Presents
Innovations in Peptide Science 2025
BioCity, Nottingham, UK
July 1st 2025
Join academic experts, biotech pioneers, and drug development specialists for a one-day event focused on the next generation of peptide-based therapeutics. This conference will bring together leaders in the peptide community across academia, industry and pharma to explore the latest scientific and clinical dimensions of peptide innovation.
Key topics include
- Novel peptide synthesis platforms and discovery strategies
- Rational design and therapeutic application of peptides
- Advanced strategies for peptide cyclisation
- Peptides in catalysis and biocatalysis
- Peptide conjugation strategies
- Methods towards a greener future in peptide synthesis and purification
Featured speakers
- Don Wellings, Founder and Managing Director (SpheriTech Ltd)
- Andrew Jamieson, Professor of Chemical Biology (University of Glasgow)
- Jefferson Revell, Principal Scientist (AstraZeneca)
- Nick Mitchell, Associate Professor (University of Nottingham)
- Mark Eccleston, CEO (ValiRx)
- Anna Peacock, Reader in Bioinorganic Chemistry (University of Birmingham)
- Nara Daubeney, CEO and Co-Founder (Phaim Pharma)
- Drew Thomson, Lecturer (University of Glasgow)
- Dominik Sarma, Senior Market Manager (Gyros Protein Technologies)
- Peter Ridgway, Co-Founder (Reach Separations)
- Jordan Fletcher, Technical Director of Peptides (CatSci)
- Cameron Thorpe, Oligonucleotides Team Lead (CatSci)
Badge Registration Form
Registration is now closed.
Who Should Attend
This event is designed for professionals involved in the discovery, development, and manufacture of peptide-based therapeutics and complex synthetic medicines.
You should attend if you are:
- A scientific leader or project head advancing peptide, oligonucleotide, or hybrid modality programs
- A drug developer working on the integration of peptides with other therapeutic technologies
- A CSO, VP R&D, or Director of CMC seeking insight into emerging capabilities
- Business strategy leaders seeking insight into the future of synthetic modality innovation
- Heads of Peptide Chemistry, Principal Scientists, and Research Fellows exploring novel synthesis platforms
Join us to explore how scientific innovation in peptides is building the next generation of complex synthetic medicines.
Location and Venue
Biocity Nottingham,
Pennyfoot Street,
Nottingham,
Nottinghamshire,
NG1 1GF,
United Kingdom
Nearest Parking
There is no parking available on-site at BioCity so please use the following local car parks:
- NCP Nottingham Stoney Street
Stoney St, Nottingham, NG1 1LS - Trinity Square Car Park
North Church Street, Nottingham, NG1 4BT - Lace Market Car Park
33 Pilcher Gate, Nottingham, NG1 1QE
Nearest airports
- East Midlands Airport (11.7 miles)
- Doncaster/ Sheffield – Robin Hood Airport (37.4 miles)
- Birmingham Airport (47 miles)
Nearest train station
- Nottingham (0.5 miles)
Sponsors and Partners
Contact Us
Organising committee
Dan Croucher: dan.croucher@catsci.com
Jordan Fletcher: Jordan.fletcher@catsci.com
Sponsorship information
Dan Croucher: dan.croucher@catsci.com
Stay informed on LinkedIn